Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

Market Cap	17.94B +45.8%
Revenue (ttm)	2.41B +33.6%
Net Income	646.21M +85.4%
EPS	2.63 +84.2%
Shares Out	246.43M
PE Ratio	27.72
Forward PE	n/a
Dividend	0.80 (1.10%)
Ex-Dividend Date	Sep 24, 2025

Volume	4,836,888
Average Volume	6,989,431
Open	70.50
Previous Close	72.70
Day's Range	70.50 - 73.17
52-Week Range	47.47 - 85.65
Beta	0.47
RSI	54.01
Earnings Date	Apr 22, 2026

About SHE:300573

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. The company provides myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory/anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, and dry eye medicines. It also engages in the techn...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1977
• Employees: 2,426
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300573

Financial Performance

In 2024, SHE:300573's revenue was 1.94 billion, an increase of 32.42% compared to the previous year's 1.47 billion. Earnings were 338.06 million, an increase of 40.84%.